Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (769)	7/2/1998 6:25:00 PM
From: Peter Singleton	Read Replies (1) \| Respond to of 1510

Folks, good info on market manipulation. no question NASDAQ is dirty. it's an outrage. However, AHM made a compelling point, and one folks on this thread should be listening to, IMO. Here's my take. Just a guess, of course. The Remune news was a non-event. Carlo's comments + Johnson's comments + the message in the AGPH deal were all factored into the share price, expectations were built above what the data could justify (in the current biotech cap mkt environment), then the stock sold off, all before the news came out. Two cases where this could be wrong. One, if Valentine has something significant to say he chose not to say today ... I don't know why he would hold off, the symposium today was very high profile, and he is discussing the same data at the late-breaker session tomorrow. But I suppose it's possible. Second, if the popular press picks up the story and presents it with an optimistic spin (e.g., a NYT, WSJ featured article). What we heard today was not "investment grade" or "shocking" data, to use two terms that have been bandied about on the Yahoo board. IMO, it's promising, important data ... with big implications for HIV therapies, and Remune in particular. But it's not the blockbuster "buzz of the conference" data that many of us expected ... I also think a lot of the $ that went into the stock in anticipation of the news were in the hopes of trading profits based on the "shocking" news to be announced in Geneva ... would love to be wrong on this, but gotta call it as I see it until something changes. Peter p.s., there's a big anomaly here, though. Options continue to trade at high premiums, and today and yesterday there's been lots of calls purchased ... at the same time that there's been selling pressure. Looks like a divided opinion here. Either there's news coming quickly that hasn't been factored into the price of the stock, or there's a fair amount of folks who are hanging on to that expectation who are betting $ that that's the case. And on the other hand, while there's clear manipulation going on, there's also selling pressure, pure and simple.

To: Steve Fancy who wrote (769)	7/5/1998 10:10:00 PM
From: Manny Gugliuzza	Read Replies (3) \| Respond to of 1510

this is the same problem that Dr. Salk ran into with the polio vaccine using too much protein. created the disease in some children. now with Remune their is only core protein but inactivated (killed) but still whole just without the surrounding envelope. that simian test that Steve posted which was with a attenuated live was insane. Dr. Fred Jensen in a phone conversation that i posted a while back said they did a 2 primate study with Remune giving it to one primate and not the other. after infecting them the unprotected died. they are now doing an extensive study with primates which will be the front runner before human testing. right now i am a little confused over how many 2x a day drug therapy exists. we have the nfv + d4t and sqv +nfv which have failed but worked in combo as a capture save effort. and the new antiretroviral drugs sustiva and one from Glaxo i do not see the company or sec removing profits from short sellers unless their prove manipulation based on previous knowledge . but then i do not see any others posting here to the contrary either so maybe something is up with that. the MACD just turned negative. we are probably close to a reversal day down here similar to the one at the top with nearly half the shares of the company sold out last week starting at around 19. IS this a bonifide play for the company a split buy back?? ar.